filmov
tv
FDA Approves Gene Therapy for Leber's Congenital Amaurosis
Показать описание
Just a few years ago, Penn Medicine's Jean Bennett, MD, PhD, detailed the hopes that recently came to fruition when the FDA approved gene therapy for the treatment of a rare, inherited form of retinal blindness.
In a historic move, the U.S. Food and Drug Administration (FDA) has approved a gene therapy initially developed by researchers at the University of Pennsylvania and Children’s Hospital of Philadelphia for the treatment of a rare, inherited form of retinal blindness. The decision marks the nation’s first gene therapy approved for the treatment of a genetic disease and the first in which a new, corrective gene is injected directly into a patient.
A perfect example of Penn’s One Health initiative, early work for the therapy approved today took place in dogs with the same condition. Just a few years ago, Jean Bennett, MD, PhD, the F.M. Kirby Professor of Ophthalmology at the Perelman School of Medicine at the University of Pennsylvania and Penn’s Scheie Eye Institute, detailed her hopes for the therapy that today came to fruition.
In a historic move, the U.S. Food and Drug Administration (FDA) has approved a gene therapy initially developed by researchers at the University of Pennsylvania and Children’s Hospital of Philadelphia for the treatment of a rare, inherited form of retinal blindness. The decision marks the nation’s first gene therapy approved for the treatment of a genetic disease and the first in which a new, corrective gene is injected directly into a patient.
A perfect example of Penn’s One Health initiative, early work for the therapy approved today took place in dogs with the same condition. Just a few years ago, Jean Bennett, MD, PhD, the F.M. Kirby Professor of Ophthalmology at the Perelman School of Medicine at the University of Pennsylvania and Penn’s Scheie Eye Institute, detailed her hopes for the therapy that today came to fruition.
FDA approves Novartis gene therapy for rare genetic disorder
A 7-Year-Old's Blindness was Reversed by the 1st FDA-Approved Gene Therapy for Retinal Degenera...
FDA approves gene therapy sickle cell treatment
Why the FDA’s approval of revolutionary sickle cell gene therapy is a ‘big deal’
Why FDA's approval of genetic therapy is such a big deal
FDA approves first gene therapies for sickle cell disease
FDA approves first gene therapies to treat patients with sickle cell disease
FDA Approves Nation's First Gene Therapy For Rare Form Of Blindness
A New FDA-Approved Gene Therapy Helps Treat a Rare Childhood Cancer
FDA approves gene editing treatments that may cure sickle cell
FDA Approves First US Gene Therapy To Fight Childhood Leukemia | TODAY
FDA approves first gene therapy for sickle cell disease
FDA approves 'gene therapy' leukemia treatment
FDA Approves First Gene Therapy for Duchenne Muscular Dystrophy
Why FDA-backed gene therapy for rare form of blindness is revolutionary
FDA approves 2nd gene therapy for blood cancer
FDA Approves Gene Therapy Tested In Boston To Treat Adults With Lymphoma
FDA approves first gene therapy for rare skin disease, but costs are outrages
Gene therapy one step closer to FDA approval
Mass Eye & Ear Doctors Perform First FDA-Approved Gene Therapy For Inherited Disease
FDA approves two groundbreaking new gene therapy treatments for sickle cell disease
Gene Therapy for the Sickle Cell Diseases is Approved by the FDA
FDA approves first gene therapy for muscular dystrophy
FDA approves first gene therapy to fight childhood leukemia
Комментарии